Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Remote ischemic preconditioning causes transient cell cycle arrest and renal protection by a NF-κB–dependent Sema5B pathway
Jan Rossaint, … , Hermann Pavenstädt, Alexander Zarbock
Jan Rossaint, … , Hermann Pavenstädt, Alexander Zarbock
Published June 21, 2022
Citation Information: JCI Insight. 2022;7(14):e158523. https://doi.org/10.1172/jci.insight.158523.
View: Text | PDF
Research Article Immunology Nephrology

Remote ischemic preconditioning causes transient cell cycle arrest and renal protection by a NF-κB–dependent Sema5B pathway

  • Text
  • PDF
Abstract

Acute kidney injury increases morbidity and mortality, and previous studies have shown that remote ischemic preconditioning (RIPC) reduces the risk of acute kidney injury after cardiac surgery. RIPC increases urinary high mobility group box protein-1 (HMGB1) levels in patients, and this correlates with kidney protection. Here, we show that RIPC reduces renal ischemia-reperfusion injury and improves kidney function in mice. Mechanistically, RIPC increases HMGB1 levels in the plasma and urine, and HMGB1 binds to TLR4 on renal tubular epithelial cells, inducing transcriptomic modulation of renal tubular epithelial cells and providing renal protection, whereas TLR4 activation on nonrenal cells was shown to contribute to renal injury. This protection is mediated by activation of induction of AMPKα and NF-κB; this induction contributes to the upregulation of Sema5b, which triggers a transient, protective G1 cell cycle arrest. In cardiac surgery patients at high risk for postoperative acute kidney injury, increased HMGB1 and Sema5b levels after RIPC were associated with renal protection after surgery. The results may help to develop future clinical treatment options for acute kidney injury.

Authors

Jan Rossaint, Melanie Meersch, Katharina Thomas, Sina Mersmann, Martin Lehmann, Jennifer Skupski, Tobias Tekath, Peter Rosenberger, John A. Kellum, Hermann Pavenstädt, Alexander Zarbock

×

Figure 8

Sema5b regulates RIPC-induced renal protection from IRI in vivo.

Options: View larger image (or click on image) Download as PowerPoint
Sema5b regulates RIPC-induced renal protection from IRI in vivo.
After i...
After induction of general anesthesia, renal IRI was induced in WT and Sema5b-deficient mice by clamping of the renal pedicles for 32 minutes. Some mice received a blocking Sema5b antibody (50 μg/mouse) or were subjected to RIPCs before IRI induction. Twenty-four hours after the surgery, mice were sacrificed. (A) The recruitment of neutrophils (PMNs) into the kidney was analyzed by flow cytometry (n = 4). (B) Serum creatinine levels were measured by a photometric assay (n = 4). (C) The biomarkers TIMP-2 and IGFBP7 were measured in urine samples 24 hours after renal IRI (n = 4). (D) Quantification of histological tubular injury (n = 4). (E) Detection of injected Sema5b antibody in the plasma and urine by sandwich ELISA (n = 6). (F) Urinary levels of Sema5b in cardiac surgery patients from the RIPCrenal trial before and 4 hours after RIPC application (n = 20/group). One-way ANOVA followed by Bonferroni testing was used for statistical analysis; *P < 0.05.

Copyright © 2022 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts